374Water to Demonstrate PFAS Destruction with DoD ESTCP and Colorado School of Mines

(NASDAQ:SCWO), Environmental Security Technology Certification Program Evaluates Treatment Options for DoD Installations Impacted by PFAS DURHAM, N.C., July 10, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced the deployment of its AirSCWO technology […]

374Water to Demonstrate PFAS Destruction with DoD ESTCP and Colorado School of Mines

374Water to Demonstrate PFAS Destruction with DoD ESTCP and Colorado School of Mines GlobeNewswire July 10, 2025 Environmental Security Technology Certification Program Evaluates Treatment Options for DoD Installations Impacted by PFAS DURHAM, N.C., July 10, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “Company”), a global leader in organic waste destruction technology and

Veris Residential Completes Liquidity Enhancing Transactions

Enters into Amended Credit Facility Completes Sale of Signature Place Resulting in $80 Million Term Loan Reduction Veris Residential, Inc. (“Veris Residential” or the “Company”) (NYSE: VRE), a forward-thinking, Northeast-focused, Class A multifamily REIT, today announced the amendment of its $500 million credit facility established in April 2024. The transaction reflects Veris Residential's continued progress

Seguritech Announces the Launch of New Artificial Intelligence Platform

The Seguritech Artificial Intelligence Monitoring Operating Network (“SAIMON Tech”) Platform Helps Optimize the Management of Large Volumes of Critical Information for Public and Private Entities Seguritech, a leader in advanced security technology integration, today announced the launch of Seguritech Artificial Intelligence Monitoring Operating Network (“SAIMON Tech”) platform. SAIMON Tech is an advanced dispatch platform that

LAZYDAYS ANNOUNCES 1-FOR-30 REVERSE STOCK SPLIT

Lazydays Holdings, Inc.(“Lazydays” or the “Company”) (NasdaqCM: GORV) today announced that the Company's Board of Directors has approved the implementation of a reverse stock split (the “Reverse Stock Split”) of the Company's issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”) by a ratio of 1-for-30. The Company will effect the

BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE

Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a potential best-in-class LRRK2 inhibitor for the treatment for Parkinson's disease, continues advancing in the clinic Brenig Therapeutics, a clinical-stage biotechnology company pioneering AI-powered small-molecule therapies for neurodegenerative diseases, today announced two key executive appointments. David L. Lucchino has

Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers

KOL webinar to take place on July 22, 2025, at 1:00 p.m. ET Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, announced that it will host a key opinion leader (KOL) webinar to discuss pelareorep in metastatic pancreatic ductal adenocarcinoma (mPDAC) and other gastrointestinal cancers. The webinar will

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain

PhaseV’s AI-Powered Trial Optimizer Debuts on AWS Marketplace, Revolutionizing Clinical Trial Design and Efficiency

Biopharma and CROs Gain Direct Access to PhaseV's Leading Platform to Accelerate Clinical Trials and Cut Costs by Up to 50% PhaseV, a leader in AI/ML for clinical development, today announced the launch of its Trial Optimizerplatform, a key component of its holistic solution, on Amazon Web Services (AWS) Marketplace. This availability offers biopharma sponsors

Caroline Kennedy Rejoins U.S.-Japan Foundation Board

Caroline Kennedy – renowned diplomat, author, and attorney – has rejoined the United States-Japan Foundation Board of Trustees. https://mma.prnewswire.com/media/2728281/Caroline_Kennedy_rejoins_United_States_Japan_Foundation.jpg Kennedy served as U.S. Ambassador to Japan from 2013 to 2017. She played a critical role in the commemoration of the 70th anniversary of the end of World War II, culminating in the historic visits of

Scroll to Top